Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-034063
Filing Date
2021-10-07
Accepted
2021-10-07 20:56:34
Documents
2
Period of Report
2021-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 4813
2 POWER OF ATTORNEY brhc10029694_ex-24.htm EX-24 9955
  Complete submission text file 0001140361-21-034063.txt   16104
Mailing Address 20 BERKELEY SQUARE, MAYFAIR LONDON X0 W1J 6EQ
Business Address
Chin Mark (Reporting) CIK: 0001734389 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40881 | Film No.: 211313657

Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 (617) 351-2575
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations